Modeling Central Nervous System Injury In Vitro: Current Status and Promising Future Strategies

Kristina Pilipović1, Anja Harej Hrkać1, Natalia Kučić2

  • 1Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.

Biomedicines
|January 21, 2023
PubMed

Insights

Central nervous system (CNS) injury research faces challenges with current experimental models. This review examines in vitro platforms for traumatic brain injury and cerebral ischemia, proposing strategies for improved neuroprotective therapy development.

Area of Science:

  • Neuroscience
  • Biomedical Research
  • Cellular Biology

Background:

  • Central nervous system (CNS) injuries from trauma or ischemia/hypoxia are major causes of mortality and morbidity.
  • Despite extensive research, effective neuroprotective strategies for brain trauma and ischemia remain elusive.
  • Existing experimental models raise questions regarding their translational validity for CNS injury therapeutics.

Purpose of the Study:

  • To review commonly used in vitro models for studying traumatic brain injury (TBI) and cerebral ischemia.
  • To evaluate frequently utilized cellular platforms in CNS injury research.
  • To propose future strategies for enhancing the translational outcomes of in vitro CNS injury studies.

Main Methods:

  • Literature review of in vitro models for CNS injury.
  • Analysis of cellular platforms used in traumatic brain injury and cerebral ischemia research.
  • Discussion of ethical considerations favoring in vitro approaches.

Main Results:

  • Identification of prevalent in vitro models and cellular platforms for CNS injury research.
  • Highlighting the increasing importance of in vitro methods due to ethical considerations.
  • Analysis of limitations in current experimental models for CNS injury.

Conclusions:

  • In vitro models are crucial for advancing neuroprotection research in CNS injury.
  • Further refinement of in vitro strategies is needed to bridge the gap between preclinical findings and clinical application.
  • Developing improved in vitro models will enhance the discovery of effective treatments for brain trauma and ischemia.

Related Concept Videos